Eating Disorder Safe principles

Issue 22 | Anorexia Nervosa Genetics Initiative (ANGI)

NEDC e-Bulletin Issue 22 Introduction: Welcome to the twenty-second edition of the NEDC e-Bulletin.

Eating Disorders - Protecting your oral health

Eating Disorders and GLP-1 RAs

Glucagon-like peptide-1receptor agonists (GLP-1 RAs), such as semaglutide (Ozempic), are medications originally developed to treat type 2 diabetes.

Issue 67 | New resources and developments

NEDC e-BulletinContents: Editor’s Note Credentialing Report New PHN portal New CBT Guided Self-Help fact sheet Latest Studies Further Reading Editor’s Note:Welcome to the latest issue of the NEDC e-Bulletin, which is packed with links to new information and resources for our members.